• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[环磷酰胺与6-甲基泼尼松龙脉冲疗法治疗非特异性主动脉动脉炎急慢性期患者的初步经验]

[The initial experience of using pulse therapy with cyclophosphane and 6-methylprednisolone in patients with acute and subacute stages of nonspecific aortoarteritis].

作者信息

Pokrovskiĭ A V, Varava B N, Zotikov A E, Iudin V I

出版信息

Ter Arkh. 1990;62(1):43-6.

PMID:2185576
Abstract

The authors summarize the first experience gained with the use of pulse therapy with cyclophosphamide and 6-methylprednisolone in 18 patients with acute and subacute nonspecific aortoarteritis. Remission attained in 16 patients was attended by a decrease in objective criteria of the process acuity. It has been noted that duration of the remission was inversely proportional to the time of the inflammatory anamnesis. Provided the patients manifested exacerbation of the process, repeated courses of pulse therapy were conducted.

摘要

作者总结了对18例急性和亚急性非特异性主动脉动脉炎患者使用环磷酰胺和6-甲基泼尼松龙进行脉冲治疗所获得的初步经验。16例患者病情缓解,同时病情严重程度的客观标准有所降低。已经注意到,缓解期的持续时间与炎症病史的时间成反比。如果患者病情出现加重,则进行重复的脉冲治疗疗程。

相似文献

1
[The initial experience of using pulse therapy with cyclophosphane and 6-methylprednisolone in patients with acute and subacute stages of nonspecific aortoarteritis].[环磷酰胺与6-甲基泼尼松龙脉冲疗法治疗非特异性主动脉动脉炎急慢性期患者的初步经验]
Ter Arkh. 1990;62(1):43-6.
2
[Indications for using a method of pulsed therapy with cyclophosphamide and 6-methylprednisolone in patients with nonspecific aortoarteritis in the acute and subacute stages].[环磷酰胺和6-甲基强的松龙脉冲疗法在非特异性主动脉动脉炎急性和亚急性期患者中的应用指征]
Kardiologiia. 1990 Dec;30(12):35-9.
3
[Effects of pulse-therapy on natural anticoagulant system of the endothelium in nonspecific aortoarteritis].[脉冲疗法对非特异性主动脉动脉炎患者血管内皮天然抗凝系统的影响]
Ter Arkh. 2003;75(5):52-6.
4
[Immunologic mechanisms of the development of nonspecific aortoarteritis].
Ter Arkh. 1990;62(4):114-8.
5
[Late treatment results in arterial hypertension due to renal artery lesion in nonspecific aortoarteritis].
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1982;5(1):84-6.
6
[Treatment with superhigh corticosteroid doses (pulse therapy) of patients with the idiopathic nephrotic syndrome].
Vutr Boles. 1987;26(2):27-33.
7
[The long-term parenteral use of cyclophosphane in treating patients with systemic lupus erythematosus and central nervous system involvement].[环磷酰胺长期胃肠外给药治疗系统性红斑狼疮合并中枢神经系统受累患者]
Ter Arkh. 1995;67(5):45-7.
8
EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.欧洲抗风湿病联盟关于狼疮性肾炎的随机对照试验:脉冲环磷酰胺和甲泼尼龙对比持续环磷酰胺和泼尼松龙后接硫唑嘌呤和泼尼松龙
Ann Rheum Dis. 2004 May;63(5):525-9. doi: 10.1136/ard.2002.003574.
9
[Surgical treatment of a female patient with type III nonspecific aortoarteritis].[一名患有III型非特异性主动脉炎女性患者的外科治疗]
Angiol Sosud Khir. 2016;22(2):145-51.
10
[The use of ultrahigh doses of corticosteroids in treating the most severe variants of lupus nephritis].
Ter Arkh. 1990;62(6):50-3.